Market Place
Sourcing Support
Taro`s Generic PEG-3350 Receives Approval in US
28 Jun 2024 //
FDA
Sun Pharma Completes Taro Merger
24 Jun 2024 //
PR NEWSWIRE
Taro`s Generic Diclofenac Potassium Receives Approval in US
14 Jun 2024 //
FDA
Taro Pharma`s Generic Diclofenac Potassium Receives Approval in the U.S
14 Jun 2024 //
FDA
Taro`s Generic Acyclovir Receives Approval in US
12 Jun 2024 //
FDA
Taro shareholders approve merger with Sun Pharma
24 May 2024 //
PRESS RELEASE
Taro Shareholders Approve Merger with Sun Pharma
23 May 2024 //
PR NEWSWIRE
Taro Provides Results for Year Ended March 31, 2024
20 May 2024 //
BUSINESSWIRE
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
16 May 2024 //
REUTERS
Taro to Release Full Year Results on May 20, 2024
15 May 2024 //
BUSINESSWIRE
ISS and Glass Lewis: Recommendation for Taro Sun Pharma Merger
08 May 2024 //
BUSINESSWIRE
Taro EGM, Class Meetings For Sun Pharma Merger Approval
15 Apr 2024 //
BUSINESSWIRE
Taro Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™
28 Mar 2024 //
PR NEWSWIRE
Taro Pharma`s Generic Magnesium Sulfate Receives Approval in the U.S
19 Mar 2024 //
FDA
Taro Provides Results for December 31, 2023
25 Jan 2024 //
BUSINESSWIRE
Taro to Release Third Quarter Results on January 25, 2024
19 Jan 2024 //
BUSINESSWIRE
Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 mln
17 Jan 2024 //
REUTERS
Sun Pharma revises upwards price to fully acquire Taro to USD 43 per share
12 Dec 2023 //
ECONOMIC TIMES
Enforcement Report - Week of November 15, 2023
15 Nov 2023 //
FDA
Taro`s Generic Rivaroxaban Receives Approval in the U.S.
03 Nov 2023 //
FDA
Taro Provides Results for September 30, 2023
26 Oct 2023 //
BUSINESSWIRE
Taro to Release Second Quarter Results on October 26, 2023
19 Oct 2023 //
BUSINESSWIRE
Taro stake buyout to help operate its dermatology biz enhanced competition
27 Aug 2023 //
ECONOMICTIMES
Taro Pharm`s Generic Ibuprofen Receives Approval in the U.S.
08 Aug 2023 //
FDA
Taro Provides Results for the Quarter Ended June 30, 2023
26 Jul 2023 //
BUSINESSWIRE
Krensavage Asset Management Opposes Sun`s Lowball Bid for Taro
19 Jul 2023 //
PR NEWSWIRE
Taro to Release First Quarter Results on July 26, 2023
19 Jul 2023 //
BUSINESSWIRE
Sun Pharma proposes to acquire Israel-based Taro Pharmaceutical Industries
28 May 2023 //
BUSINESS STANDARD
Taro Provides Results for Year Ended March 31, 2023
23 May 2023 //
BUSINESSWIRE
Taro to Release Full Year Results on May 23, 2023
18 May 2023 //
BUSINESSWIRE
Sun settles up in yearslong price-fixing litigation
14 Mar 2023 //
FIERCE PHARMA
Sun Pharma, Taro reach $75M settlement agreement in alleged price fixing scheme
13 Mar 2023 //
ENDPTS
Taro Provides Results for December 31, 2022
24 Jan 2023 //
BUSINESSWIRE
Taro to Release Third Quarter Results on January 24, 2023
19 Jan 2023 //
BUSINESSWIRE
Taro`s Generic Tretinoin Receives Approval in the U.S.
05 Jan 2023 //
FDA
Taro to Release Second Quarter Results on October 27, 2022
24 Oct 2022 //
BUSINESSWIRE
Taro Pharmaceuticals Inc. Issues Voluntary Type I Recall Taro-Zoledronic Acid
11 Aug 2022 //
BUSINESSWIRE
Taro Pharma Issues Voluntary Type I Recall of Taro-Zoledronic Acid Injection
11 Aug 2022 //
BUSINESSWIRE
Health Canada Issues Recall of Taro Pharma`s Zoledronic Acid
10 Aug 2022 //
HEALTH CANADA
Taro Provides Results for the Quarter Ended June 30, 2022
27 Jul 2022 //
BUSINESSWIRE
Taro to Release First Quarter Results on July 27, 2022
26 Jul 2022 //
BUSINESSWIRE
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022
26 Jul 2022 //
BUSINESSWIRE
Taro Provides Results for the Year Ended March 31, 2022
26 May 2022 //
BUSINESSWIRE
Taro Pharma`s Generic Fluphenazine Hydrochloride Receives Approval in U.S.
14 Apr 2022 //
FDA
Enforcement Report - Week of April 6, 2022
06 Apr 2022 //
FDA
Sun Pharma`s US subsidiary acquires Galderma`s companies in US, Japan & Canada
09 Mar 2022 //
ECONOMIC TIMES
Taro Completes Acquisition of Alchemee
01 Mar 2022 //
BUSINESSWIRE
Taro to Acquire Alchemee From Galderma
22 Feb 2022 //
BIOSPACE
Taro Provides Results for December 31, 2021
27 Jan 2022 //
BUSINESSWIRE
Enforcement Report - Week of January 19, 2022
19 Jan 2022 //
FDA
Taro Pharm`s Generic Adapalene Receives Approval in the U.S.
14 Jan 2022 //
FDA
Pharmaceutical ManufacturersPay Hundreds Millions to Settle Price-Fixing Charges
10 Dec 2021 //
PHARMACYTIMES
Taro Pharma`s Generic Sildenafil Citrate Receives Approval In US
19 Nov 2021 //
FDA
Taro Pharma`s Generic Oxymetazoline HCL Receives Approval In US
07 Oct 2021 //
FDA
Three generic drug makers to pay $450M to settle civil price fixing charges
05 Oct 2021 //
STATNEWS
Taro Provides Results for Quarter Ended June 30, 2021
29 Jul 2021 //
BUSINESSWIRE
Taro Provides Results for Quarter Ended June 30, 2021
27 Jul 2021 //
PR NEWSWIRE
Taro to Announce First Quarter Results on July 27, 2021
20 Jul 2021 //
BUSINESSWIRE
Taro Announces Resignation of Chief Financial Officer
14 Jul 2021 //
BUSINESS WIRE
